• Attention Members and Providers: Tudorza Pressair Inhaler Recall

    Attention Members and Providers: MHS wants you to know about a recent drug recall. The U.S. Food and Drug Administration (FDA) issued an Enforcement Report regarding AstraZeneca Pharmaceuticals LP. It is for Tudorza Pressair Inhaler (aclindinium bromide inhalation powder), 400 mcg per actuation, 60 Metered Doses per inhaler (prescription only). The FDA issued the recall…

    Read More...
  • Member Eligibility Notification

    Member Eligibility Notification  MHS recently sent some members a letter by mistake, stating that the member’s HIP coverage was ending on April 30th. We have notified the affected members and assured them that their coverage remains current, with no break in coverage. MHS apologizes if this error caused any confusion. Please remember to always check…

    Read More...
  • Home Health Billing

    Please see below for important details and helpful tips for home health billing of occurrence codes. You can reach out to your Provider Relations representative or contact Provider Services through your secure portal account or at 1-877-647-4848 with any questions. Thank you for being our partner in care. Home Health Billing: Web Portal Occurrence codes…

    Read More...
More News